Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

63 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
FDG-PET in patients with fever of unknown origin: the importance of diagnosing large vessel vasculitis.
Meller J, Sahlmann CO, Gürocak O, Liersch T, Meller B. Meller J, et al. Among authors: meller b. Q J Nucl Med Mol Imaging. 2009 Feb;53(1):51-63. Q J Nucl Med Mol Imaging. 2009. PMID: 19182728 Review.
Monitoring of a new approach of immunotherapy with allogenic (111)In-labelled NK cells in patients with renal cell carcinoma.
Meller B, Frohn C, Brand JM, Lauer I, Schelper LF, von Hof K, Kirchner H, Richter E, Baehre M. Meller B, et al. Eur J Nucl Med Mol Imaging. 2004 Mar;31(3):403-7. doi: 10.1007/s00259-003-1398-4. Epub 2003 Dec 19. Eur J Nucl Med Mol Imaging. 2004. PMID: 14685783 Clinical Trial.
Novel Carcinoembryonic-Antigen-(CEA)-Specific Pretargeting System to Assess Tumor Cell Viability after Irradiation of Colorectal Cancer Cells.
Meller B, Rave-Fränck M, Breunig C, Schirmer M, Baehre M, Nadrowitz R, Liersch T, Meller J. Meller B, et al. Among authors: meller j. Strahlenther Onkol. 2011 Feb;187(2):120-6. doi: 10.1007/s00066-010-2191-5. Epub 2011 Jan 24. Strahlenther Onkol. 2011. PMID: 21271227
Enhancing PSMA-uptake with androgen deprivation therapy - a new way to detect prostate cancer metastases?
Leitsmann C, Thelen P, Schmid M, Meller J, Sahlmann CO, Meller B, Trojan L, Strauss A. Leitsmann C, et al. Among authors: meller b. Int Braz J Urol. 2019 May-Jun;45(3):459-467. doi: 10.1590/S1677-5538.IBJU.2018.0305. Int Braz J Urol. 2019. PMID: 30901173 Free PMC article.
68Ga-Pentixafor PET/CT Imaging of Chemokine Receptor CXCR4 in Chronic Infection of the Bone: First Insights.
Bouter C, Meller B, Sahlmann CO, Staab W, Wester HJ, Kropf S, Meller J. Bouter C, et al. Among authors: meller b. J Nucl Med. 2018 Feb;59(2):320-326. doi: 10.2967/jnumed.117.193854. Epub 2017 Jul 20. J Nucl Med. 2018. PMID: 28729430 Free article.
18F-FDG-PET/CT in unexplained elevated inflammatory markers. Joining entities.
Bouter C, Braune I, Meller B, Sahlmann C, Ritter C, Meller J. Bouter C, et al. Among authors: meller b, meller j. Nuklearmedizin. 2016 Dec 6;55(6):242-249. doi: 10.3413/Nukmed-0798-16-02. Epub 2016 Sep 12. Nuklearmedizin. 2016. PMID: 27617327
Biphasic ⁶⁸Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinoma.
Sahlmann CO, Meller B, Bouter C, Ritter CO, Ströbel P, Lotz J, Trojan L, Meller J, Hijazi S. Sahlmann CO, et al. Among authors: meller b, meller j. Eur J Nucl Med Mol Imaging. 2016 May;43(5):898-905. doi: 10.1007/s00259-015-3251-y. Epub 2015 Nov 12. Eur J Nucl Med Mol Imaging. 2016. PMID: 26563122
Semiquantitative PET data (SUVmax, SUV mean) were acquired and target-to-background-ratios (T/B-ratio) were calculated for benign and malign lesions for both time points. ...Benign lesions had significantly lower SUVmax and T/B-ratios compared with malignant finding …
Semiquantitative PET data (SUVmax, SUV mean) were acquired and target-to-background-ratios (T/B-ratio) were calculated for benign and …
Conventional gamma and high energy probe for radioguided dissection of metastases in a patient with recurrent thyroid carcinoma with (99m)Tc-MIBI and (18)F-FDG.
Meller B, Sahlmann C, Horstmann O, Gerl J, Baehre M, Meller J. Meller B, et al. Among authors: meller j. Nuklearmedizin. 2005;44(3):N23-5. Nuklearmedizin. 2005. PMID: 15997503 No abstract available.
Diagnostic 123I and 131I activities and radioiodine therapy. Effects on urinary iodine excretion in patients with differentiated thyroid carcinoma.
Meller B, von Hof K, Genina E, Deisting W, Meller J, Richter E, Baehre M. Meller B, et al. Among authors: meller j. Nuklearmedizin. 2005;44(6):243-8. Nuklearmedizin. 2005. PMID: 16400384
These patients received 370 MBq 131I for diagnostic use and served as controls. 58 patients (group B) with remnants, relapses and metastases received 370 MBq 123I for diagnostics prior to therapy with 1.5-22.2 GBq 131I. ...As well, UIE remained unchanged after diagnostic a …
These patients received 370 MBq 131I for diagnostic use and served as controls. 58 patients (group B) with remnants, relapses and met …
Pelvic lymph node dissection for nodal oligometastatic prostate cancer detected by 68Ga-PSMA-positron emission tomography/computerized tomography.
Hijazi S, Meller B, Leitsmann C, Strauss A, Meller J, Ritter CO, Lotz J, Schildhaus HU, Trojan L, Sahlmann CO. Hijazi S, et al. Among authors: meller b, meller j. Prostate. 2015 Dec;75(16):1934-40. doi: 10.1002/pros.23091. Epub 2015 Sep 10. Prostate. 2015. PMID: 26356236
63 results
Jump to page
Feedback